Although a number of risk factors for cardiovascular morbidity and mortality have been identified in young and middle-aged adults, their prevalence and importance are less known in the elderly. Elderly people have a risk profile different from that of younger subjects, but representative data on risk factors for cardiovascular disease in the elderly are difficult to find in the literature. Some typical 'major' risk factors, like blood pressure (BP), total cholesterol or left ventricular hypertrophy, do
Introduction
A number of cardiovascular risk factors have been identified in young and middle-aged adults; many of these factors, such as hypertension, high cholesterol, cigarette smoking, and diabetes, have an unquestionable relationship with cardiovascular mortality and morbidity and are designated as 'major'.
The prevalence and importance of these risk factors and their impact on mortality are less known in the elderly. In fact, subjects over 65 years of age have often been excluded from clinical and epidemiological trials and truly representative data on risk factors for cardiovascular disease in the elderly are difficult to find. It is therefore hard to say if they can be considered as 'major' also in the extreme ages. Thus it is important to identify what risk factors are still 'operative' in the elderly, because cardiovascular disease remains the commonest cause of mortality in persons over the age of 65 years.
Blood pressure (BP)
Hypertension is a major contributor to cardiovascular disease, accelerating atherogenesis and promoting premature coronary artery disease (CAD). Although its effect is independent of other atherogenic cofactors, elevated BP is often associated with hyperlipidaemia, hyperglycaemia, hyperuricaemia, excessive weight, elevated fibrinogen, and cardiac abnormalities, which enhance its impact on the target organs.
The age-related rise in BP (at least systolic) is a 'natural' consequence of growing old (Figure 1) , and the prevalence of isolated systolic hypertension 1 greater than 30% over the age of 65. Aortic calcium content increasing by 500 times from birth to oldest ages explains why in the elderly, systolic BP (SBP) progressively increases in spite of a reduced cardiac output. The age-related structural changes in the vascular system are believed to amplify the effect of the alerting BP response to the doctor's visit resulting in much higher SBP levels at clinic measurement. Decreased arterial compliance coupled with impaired baroreflex function may also magnify BP oscillations in response to pressor stimuli. 2 Therefore, several authors claimed that systolic hypertension is not a sustained condition, but a short-lasting response to office BP measurement. 3 This may explain why the prognostic value of BP is less distinct in the elderly than in younger subjects. According to some authors 4 BP in the elderly is a weak predictor of mortality, and Langer et al 5 even found a paradoxical advantage for survival in men with higher diastolic BP (DBP). This paradox seems to be particularly evident in the very old.
Data obtained from 2254 elderly subjects from the general population of the CASTEL (CArdiovascular STudy in the ELderly) 6 support this view, as we were unable to demonstrate any direct role of hypertension in the prediction of mortality. Both hypertension and BP were in fact rejected from Cox analysis. After dividing subjects into normotensives, borderline hypertensives and sustained hypertensives (у160 or у95 mm Hg or treated), we found that cardiovascular mortality in longitudinal study was similar in the three categories. However, the confounding effect of anti-hypertensive treatment prevented any definite conclusion on this issue.
Admittedly, at variance with our results, other authors have sometimes shown that arterial hypertension plays a role for excess cardiovascular morbidity also in elderly subjects. 7, 8 According to the Framingham Study, some 30-60% of all cardiovascular diseases in the elderly appears to be attributable to either mild or severe hypertension. 9 Even if we accept the idea that BP levels may have a low prognostic value in the elderly, this does not imply sic et simpliciter that therapy is ineffective. Treatment of hypertension in the elderly has been shown to be beneficial, even though some controversy still remains. A body of evidence actually suggests that treatment with anti-hypertensive drugs might prevent cardiovascular complications in 1.1-2.2% of patients each year and fatal cardiovascular complications in 0.5-1.3% per year. 10 This could partly be due to non-haemodynamic effects of drugs, such as reduction of left ventricular mass, arterial wall thickness and peripheral resistance. On the other hand, the relative risk of treated hypertensives aged у65 years remains high in comparison with the normotensives; failure to restore 'normal' BP values may be one reason, but the existence in some elderly hypertensives of an element of irreducible risk cannot be excluded. The best class of drugs to be employed in the elderly and the optimal degree of BP reduction also need to be defined.
Finally, the question as to whether high BP is a risk factor in very old subjects is open to debate. In our experience, 11 as well as in that of others, 12 it is a very poor predictor of mortality. Furthermore, in very old persons the BP-related mortality curve is clearly U-shaped and the highest mortality rate can actually be found in the lowest BP classes, ie, Ͻ130 mm Hg systolic and Ͻ80-85 mm Hg diastolic. Langer et al 5 described a 'paradoxical survival' in elderly men 75 years of age or more having the highest BP values (the ongoing HOT study will probably clarify this problem).
Serum total cholesterol (TC)
TC is not a definite risk factor in the elderly. 13 The paradoxical possibility that a high TC is associated with longer, rather than shorter, survival in subjects in the 7th decade of life has been suggested in 1990 by the results of the EWPHE, 14 where TC measured at randomisation was independently and inversely correlated with total mortality.
In our experience based on elderly subjects from the general population of the Veneto region (northeast Italy), 12-year cardiovascular mortality rate was not greater in the hypercholesterolaemic than in the normocholesterolaemic subjects, and overall mortality was even lower in the former 11 ( Figure 2 ). The inverse relationship between TC levels and overall mortality was confirmed in a multivariate model when other risk factors were taken into account. A low TC can actually reflect malnutrition or cancer.
At variance with the above-mentioned observations, other authors found in Scandinavian or North American elderly subjects a J-shaped relation between TC and mortality 15, 16 ; these studies were not population-based, however.
Another confounding factor is that in the elderly, as well as in younger people, TC is not a pure predictor of mortality or morbidity, but is often associated to other risk factors. For instance, TC and BP correlate directly to one another at all ages, and elderly diabetic patients usually have higher values of TC than coeval non-diabetic subjects.
11 Consequently, particularly when TC is only mildly elevated, its prognostic value must be carefully evaluated in relation to other risk factors common in the elderly.
In the very old, mortality tends to be lower in the highest quintiles of TC. This cannot be merely attributed to a higher incidence of cancer in the lower TC classes, as cancer mortality was similar in the different classes. Furthermore, both TC and triglyceride levels (TG) are higher in females than in males, although mortality is higher in the latter than in the former.
The question as to whether the modern drugs reducing TC are able to reduce the incidence of morbid events also in the elderly has not yet been answered.
HDL-cholesterol and ApoA/ApoB ratio
High density lipoprotein (HDL) fraction and particularly the ratio of apolipoprotein A to B are considered to be better risk indicators than TC in the elderly.
We studied this topic by comparing elderly subjects from two northern Italian towns, Castelfranco (industrial) and Chioggia (rural, on the sea). In the latter, TC was on average lower than in the former (204 ± 44 vs 226 ± 43 mg/dl, P Ͻ 0.0001) and also lower than the average value for Italians, but cardiovascular mortality was similar in the two cohorts. A possible explanation is that the Castelfranco elderly subjects also had a higher level of HDL (65 ± 19 vs 48 + 19 mg/dl, P Ͻ 0.0001). Moreover, taking into account the two cohorts together, relative risk for cardiovascular death increased significantly with increasing ApoA/ApoB ratio.
Triglycerides (TG)
In our survey, TG was a predictor of cardiovascular mortality in elderly men but not in women. In the former, relative risk was low for the lowest values of TG, was equal to 1 in the middle quintile, and showed a sudden increase (1.75) in the last one. We are therefore unable to confirm the hypothesis of La Rosa et al 17 who suggested that TG is a stronger predictor of cardiovascular risk in females than it is in males.
TG also correlated with uric acid (P Ͻ 0.0001), TC (P Ͻ 0.0001), blood glucose (P Ͻ 0.0001) and heart rate (P Ͻ 0.02). Furthermore, the prevalence of hypertension, of hypercholesterolaemia, and of murmurs at the neck was higher in subjects with more elevated TG.
Impaired glucose tolerance (IGT)
IGT is one of the commonest chronic diseases in the elderly. In the United States 10% of the elderly are diabetic and 43% of diabetics fall in the age group of 65 years or over.
Although IGT is considered an important risk factor in young and middle-aged subjects, its role in the elderly is still under debate. Diabetes predicts CAD and complications of myocardial infarction in the elderly, 18 and in the Framingham Study CAD was even related to blood glucose. 19 Whereas, in the Finnish cohorts of the Seven Countries Study, IGT was a predictor of cardiovascular mortality only in subjects under the age of 74 years. These data indicate that IGT is probably an important ingredient of the risk profile also in the elderly. However, the risk associated with it varies widely, depending on the associated risk factors and tends to decrease with increasing age. 20 In the CASTEL cohort, 21 1842 subjects had a normal glucose tolerance at the initial screening, 237 had borderline IGT (120-140 mg/dl), and 175 were diabetic. Subjects with overt diabetes or borderline IGT had greater mortality than normoglicaemic subjects and similar to one another, indicating that IGT has a predictive power for mortality as great as that of diabetes.
In subjects aged 80 years or over, however, IGT was not a predictor of mortality, in agreement with the results of the Seven Countries Study.
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Left ventricular hypertrophy (LVH)
Several studies have shown that LVH is an independent risk factor for morbidity and mortality. The first evidence was provided by the Framingham Study, which showed that definite LVH ECG increased the risk of CAD three-fold after adjustment for the effect of coexisting hypertension, and that possible LVH ECG was associated with a two-fold increased risk. Subsequent studies performed with echocardiography showed that there was a 50% increase in the relative risk for every 50 g/m height or left ventricular mass index. 23 The above mentioned studies were carried out mainly in middle-aged subjects and their results cannot be acritically inferred to the elderly.
Among 552 subjects 24 from an Italian general population, the prevalence of LVH assessed echocardiographically (LVH echo ) was similar in the normotensives and the hypertensives. At the 12th year of follow-up, 158 subjects had died (83 for cardiovascular causes). LVH echo was not included in the Cox equation of risk for cardiovascular death.
In the literature, data derived from elderly subjects are sparse and virtually confined to the Framingham and the Aronow's studies, 25, 26 which found among subjects in the 6th to 8th decade of life a higher mortality rate and a higher incidence of cardiovascular events in those having LVH ECG or LVH echo than in those without LVH. Many of these effects of LVH could be simply due to coexistent hypertension (in the past, a logistic approach was not systematically applied), and some studies actually showed negative results.
Other ECG abnormalities
The prevalence of ECG abnormalities is higher in the more advanced age groups. Nevertheless, the prognostic value of different ECG items has not been systematically investigated in elderly people and information about this age group is sparse. This issue was dealt with in 2254 elderly subjects from the CAS-TEL. 27 A logistic regression showed a predictive role for overall mortality of ECG signs of ischaemia, bundle branch block (BBB) and atrio-ventricular block in males, and of ischaemia, myocardial infarction, BBB and atrial fibrillation in females. Taking into consideration cardiovascular mortality, atrial fibrillation, left BBB and ischaemia were predictors in both sexes, right BBB, LVH and supraventricular tachycardia were predictors in men, and A-V block in females. These data are in agreement with the results of most authors.
However, in the CASTEL, codes for myocardial infarction-both isolated or associated to ST-T abnormalities-did not predict cardiovascular mortality in men. Therefore, we cannot confirm the results of other authors, who found the Q or QS pattern to be always a strong predictor of mortality in men.
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Proteinuria
The importance of proteinuria has been underestimated for a long time, even though several studies demonstrated that it is an important risk indicator whose predictive value for overall and cardiovascular mortality remains even when other independent variables-such as hypertension, cigarette smoking, alcohol intake, serum cholesterol and diabetes mellitus-are included in multivariate models.
In our experience, a positive dipstick was a very common finding in the general population, 29 its frequency increasing with advancing age. In a multivariate Cox analysis proteinuria emerged as one of the most important risk indicators in 3283 elderly subjects (Figure 3) . Different results were obtained in the 'very old' subjects, in whom the prognostic power of proteinuria was inverted, being the nonalbuminuric subjects paraxodically at higher risk than the albuminuric ones.
In the elderly, proteinuria did not simply reflect the existence of hypertension. In fact, it was not more prevalent in the hypertensives than in the normotensives. The association of hypertension and albuminuria carried an increased cardiovascular risk in comparison to the subjects with only one of the two items.
Ventilatory function
In all the analyses performed in our populations 11, 22 a reduced ventilatory function was constantly a strong predictor of mortality. This can be clearly inferred from the two survival curves shown in Figure 4 . A clear departure toward lower survival can be observed, particularly after the 2nd year of follow-up, in subjects with reduced FEV 1 .
During a population survey in 1986/1987 among community-dwelling Polish elderly aged 65 years and over, measurements of ventilatory lung function were carried out in 698 males and 1211 females by Jedrychowski et al. 30 These authors found that in addition to age, FEV 1 was the most relevant independent predictor of survival among the elderly. Similar results were obtained in the Framingham Study. 31 There are some concerns about snoring and nocturnal apnea, a habit which could predispose to an increased risk through a reduced ventilatory function during the night-time. Jennum et al 32 recently concluded that there was a slightly increased risk that did not reach statistical significance in snorers, but after multivariate adjustment snoring was not associated with any additional risk in elderly men.
Serum uric acid (UA)
A possible prognostic value of increased levels of UA has been emphasised in the last years. In 1989 Levine et al 33 described a strong and significant association between serum UA and overall mortality in the women of the cohort of the Chicago Heart Association Detection Project in Industry, 33 where hypertensive subjects and those aged more than 64 years were excluded.
Our experience indicates that in elderly subjects UA is a strong predictor of mortality and, thus, is an important test in the assessment of elderly subjects. In the very old, the relationship between UA and mortality is J-shaped and remains significant also after adjustment for confounders.
There is no evidence, up-to-date, that pharmacological reduction of abnormally elevated UA can reduce the cardiovascular risk.
Heart rate
In recent years evidence has been accumulating that the heart rate is associated with risk of death (both cardiovascular and non-cardiovascular). 34, 35 Resting heart rate has been found to predict CAD independently from other major risk factors. 36 Very little is known on the relation between heart rate and mortality in the elderly. In the CASTEL heart rate actually turned out to be a strong predictor of cardiovascular mortality, at least in males: in 1266 elderly men, the higher the heart rate, the worse the outcome, with a significant steep increase in mortality over the value of 78 bpm ( Figure 5 ). An increase of heart rate from 60 to 90 bpm led to a three-fold increase of the relative risk.
In women, heart rate was not a definite predictor of cardiovascular mortality and was rejected from the Cox equation, although relative risk was higher in the highest quintile of heart rate.
Tachycardia is a strong marker of sympathetic tone. The metabolic consequences of increased sym- ). RR is the relative risk.
pathetic tone and the haemodynamic effects of faster ejection are independently conducive to vascular damage and to development of atherosclerosis. A fast heart rate can also be an early marker of cardiac dysfunction and decreased cardiac reserve.
Plasma fibrinogen (PF)
The epidemiology of PF is similar to that of TC: PF levels increase with increasing age and are greater in smoking, obese, hypertensive or diabetic subjects. PF levels over 220 mg/dl are related to an increased cardiovascular risk in the elderly as well as in younger ages.
Conclusions
Elderly subjects have a risk pattern for cardiovascular mortality different from that of younger people. Items which are considered typical risk factors in the young adult, such as BP, TC or LVH, do not seem to have a clear predictive role in the elderly. On the contrary, other risk indicators that are usually labelled as 'minor' in the middle-aged person, like UA, ventilatory function or proteinuria, do have a strong predictive value in the elderly. In the very old subjects the number of risk factors is even smaller, being probably limited to IGT, UA and FEV 1 . This must be taken into account when evaluating the cumulat- ive risk of elderly subjects. The possibility exists of overtreating elderly subjects with BP of TC over the so-called normal range, and of overlooking important tests in the patient's assessment.
